Suppr超能文献

人 Fc 受体样 5 通过与 Fc 受体不同的机制结合完整 IgG。

Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

机构信息

Division of Monoclonal Antibodies, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.

出版信息

J Immunol. 2013 Jun 1;190(11):5739-46. doi: 10.4049/jimmunol.1202860. Epub 2013 Apr 24.

Abstract

Fc receptor-like (FCRL) 5 regulates B cell Ag receptor signaling and has been reported to bind aggregated IgG. Using surface plasmon resonance, we analyzed the interaction of native IgG samples with FCRL5, revealing a complex binding mechanism, where isotype is just one factor. FCRL5 bound IgG1 and IgG4 with ~1 μM KD, whereas the interaction with IgG3 was a magnitude weaker. However, IgG2 samples displayed a wide range of affinities, indicating that additional factors affect binding. We used a panel of 19 anti-FCRL5 mAbs with defined reactivity to identify domains involved in ligand binding. Six mAbs blocked IgG binding, indicating critical roles of FCRL5 domains 1 and 3, as well as epitopes at the domain 1/2 and domain 2/3 boundaries. We found that only glycosylated IgG containing both Fab arms and the Fc region bound with high affinity. Furthermore, the presence of sialic acid in the IgG carbohydrate altered FCRL5 binding. The interaction of IgG and FCRL5 consisted of two kinetic components, suggesting a complex binding mechanism. We established that the IgG-Fc and IgG-F(ab')2 fragments bind FCRL5 independently but with low affinity, revealing the mechanism behind the two-step binding of whole IgG. This complex binding mechanism is distinct from that of Fc receptors, which bind through the Fc. We propose that FCRL5 is a new type of receptor that recognizes intact IgG, possibly enabling B cells to sense Ig quality. Recognition of undamaged IgG molecules by FCRL5 could allow B cells to engage recently produced Abs.

摘要

Fc 受体样(FCRL)5 调节 B 细胞抗原受体信号转导,并已被报道可与聚集的 IgG 结合。我们使用表面等离子体共振分析了天然 IgG 样品与 FCRL5 的相互作用,揭示了一种复杂的结合机制,其中同种型只是一个因素。FCRL5 以~1μM KD 结合 IgG1 和 IgG4,而与 IgG3 的相互作用则弱一个数量级。然而,IgG2 样品显示出广泛的亲和力范围,表明其他因素影响结合。我们使用了一组具有明确反应性的 19 种抗 FCRL5 mAb 来鉴定参与配体结合的结构域。6 种 mAb 阻断了 IgG 的结合,表明 FCRL5 结构域 1 和 3 以及结构域 1/2 和结构域 2/3 边界的表位起关键作用。我们发现只有含有两个 Fab 臂和 Fc 区的糖基化 IgG 才能高亲和力结合。此外,IgG 碳水化合物中唾液酸的存在改变了 FCRL5 的结合。IgG 和 FCRL5 的相互作用由两个动力学组成部分组成,表明存在复杂的结合机制。我们确定 IgG-Fc 和 IgG-F(ab')2 片段独立但以低亲和力结合 FCRL5,揭示了整个 IgG 两步结合的背后机制。这种复杂的结合机制与 Fc 受体不同,Fc 受体通过 Fc 结合。我们提出 FCRL5 是一种识别完整 IgG 的新型受体,可能使 B 细胞能够感知 Ig 质量。FCRL5 对未受损 IgG 分子的识别可能使 B 细胞能够结合最近产生的 Abs。

相似文献

1
Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.
J Immunol. 2013 Jun 1;190(11):5739-46. doi: 10.4049/jimmunol.1202860. Epub 2013 Apr 24.
2
Human Fc receptor-like 5 distinguishes IgG2 disulfide isoforms and deamidated charge variants.
Mol Immunol. 2017 Dec;92:161-168. doi: 10.1016/j.molimm.2017.10.020. Epub 2017 Nov 2.
3
Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.
J Immunol. 2012 May 15;188(10):4741-5. doi: 10.4049/jimmunol.1102651. Epub 2012 Apr 9.
4
6
Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells.
J Immunol. 2016 May 15;196(10):4064-74. doi: 10.4049/jimmunol.1501027. Epub 2016 Apr 13.
7
Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes.
J Leukoc Biol. 2012 Jan;91(1):59-67. doi: 10.1189/jlb.0211096. Epub 2011 Oct 25.

引用本文的文献

1
CAR-T cell therapy in Multiple Myeloma: current status and future challenges.
Blood Cancer J. 2024 Nov 26;14(1):206. doi: 10.1038/s41408-024-01191-8.
2
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma.
Cancers (Basel). 2024 Jun 26;16(13):2337. doi: 10.3390/cancers16132337.
3
Impact of structural modifications of IgG antibodies on effector functions.
Front Immunol. 2024 Jan 8;14:1304365. doi: 10.3389/fimmu.2023.1304365. eCollection 2023.
5
Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
Front Immunol. 2023 Sep 28;14:1276014. doi: 10.3389/fimmu.2023.1276014. eCollection 2023.
6
FCRL1 immunoregulation in B cell development and malignancy.
Front Immunol. 2023 Sep 25;14:1251127. doi: 10.3389/fimmu.2023.1251127. eCollection 2023.
7
T-cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions.
EJHaem. 2023 Jun 6;4(3):811-822. doi: 10.1002/jha2.729. eCollection 2023 Aug.
8
The unique properties of IgG4 and its roles in health and disease.
Nat Rev Immunol. 2023 Nov;23(11):763-778. doi: 10.1038/s41577-023-00871-z. Epub 2023 Apr 24.
9
Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety.
Cancers (Basel). 2023 Mar 17;15(6):1819. doi: 10.3390/cancers15061819.
10
Evidence for Extensive Duplication and Subfunctionalization of in Armadillo ().
Int J Mol Sci. 2023 Feb 25;24(5):4531. doi: 10.3390/ijms24054531.

本文引用的文献

1
FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma.
Mol Cancer Ther. 2012 Oct;11(10):2222-32. doi: 10.1158/1535-7163.MCT-12-0087. Epub 2012 Jul 17.
3
Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.
J Immunol. 2012 May 15;188(10):4741-5. doi: 10.4049/jimmunol.1102651. Epub 2012 Apr 9.
4
Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes.
J Leukoc Biol. 2012 Jan;91(1):59-67. doi: 10.1189/jlb.0211096. Epub 2011 Oct 25.
5
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis.
Sci Transl Med. 2011 Sep 21;3(101):101ra92. doi: 10.1126/scitranslmed.3002432.
7
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA.
Int Immunol. 2011 Jan;23(1):43-53. doi: 10.1093/intimm/dxq456. Epub 2010 Dec 13.
8
FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells.
J Immunol. 2010 Dec 15;185(12):7405-12. doi: 10.4049/jimmunol.1002305. Epub 2010 Nov 10.
9
Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses.
J Immunol. 2010 Sep 1;185(5):2960-7. doi: 10.4049/jimmunol.1001428. Epub 2010 Jul 28.
10
Cutting edge: FcR-like 6 is an MHC class II receptor.
J Immunol. 2010 Jul 1;185(1):23-7. doi: 10.4049/jimmunol.1000832. Epub 2010 Jun 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验